dasatinib

Product NDC
70771-1903
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
dasatinib
Dosage form
TABLET
Route
ORAL
Labeler
Zydus Lifesciences Limited
Application
ANDA218719
Marketing category
ANDA
Substance
DASATINIB
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
70771-1903-660 TABLET in 1 BOTTLE (70771-1903-6) 2025-03-03NoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
Dasatinib Tablets for Oral UseZydus Lifesciences Limited2025-03-04HUMAN PRESCRIPTION DRUG LABEL1